Correlation Between RenovoRx and Protara Therapeutics
Can any of the company-specific risk be diversified away by investing in both RenovoRx and Protara Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RenovoRx and Protara Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RenovoRx and Protara Therapeutics, you can compare the effects of market volatilities on RenovoRx and Protara Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RenovoRx with a short position of Protara Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of RenovoRx and Protara Therapeutics.
Diversification Opportunities for RenovoRx and Protara Therapeutics
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between RenovoRx and Protara is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding RenovoRx and Protara Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protara Therapeutics and RenovoRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RenovoRx are associated (or correlated) with Protara Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protara Therapeutics has no effect on the direction of RenovoRx i.e., RenovoRx and Protara Therapeutics go up and down completely randomly.
Pair Corralation between RenovoRx and Protara Therapeutics
Given the investment horizon of 90 days RenovoRx is expected to generate 0.9 times more return on investment than Protara Therapeutics. However, RenovoRx is 1.11 times less risky than Protara Therapeutics. It trades about 0.36 of its potential returns per unit of risk. Protara Therapeutics is currently generating about 0.21 per unit of risk. If you would invest 98.00 in RenovoRx on August 29, 2024 and sell it today you would earn a total of 38.00 from holding RenovoRx or generate 38.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
RenovoRx vs. Protara Therapeutics
Performance |
| Timeline |
| RenovoRx |
| Protara Therapeutics |
RenovoRx and Protara Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with RenovoRx and Protara Therapeutics
The main advantage of trading using opposite RenovoRx and Protara Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RenovoRx position performs unexpectedly, Protara Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protara Therapeutics will offset losses from the drop in Protara Therapeutics' long position.| RenovoRx vs. Adial Pharmaceuticals | RenovoRx vs. Pasithea Therapeutics Corp | RenovoRx vs. Quoin Pharmaceuticals Ltd | RenovoRx vs. Nutriband |
| Protara Therapeutics vs. Vaccinex | Protara Therapeutics vs. Monopar Therapeutics | Protara Therapeutics vs. Surrozen | Protara Therapeutics vs. Ikena Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance |